BIO-TECHNE Corp (TECH) insider trading
Every open-market stock purchase and sale by BIO-TECHNE Corp executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- Insiders sold $437K over the last 12 months (2 sales). No open-market buys.
- Last insider buy: Robert V Baumgartner (Insider), $106K, 4 years ago.
- Congress: April McClain Delaney sold $1K to $15K, 6 months ago.
Last 12 months: insiders bought $0 (0 buys) and sold $437K (2 sales). Last close $52.65 on Jun 7, 2026.
Recent TECH insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Jun 2, 2026 | Steven C. Crouse (President) | Sold (not open market) | $10.8K |
| Jun 2, 2026 | Steven C. Crouse (President) | Bought (not open market) | — |
| May 8, 2026 | Amy E. Herr (Director) | Sold | $320K |
| May 8, 2026 | Amy E. Herr (Director) | Bought (not open market) | — |
| May 5, 2026 | James Hippel (CFO) | Sold (not open market) | $3.2M |
| May 5, 2026 | Kim Kelderman (CEO) | Sold (not open market) | $1.4M |
| May 5, 2026 | Shane Bohnen (VP) | Sold (not open market) | $400K |
| May 5, 2026 | Shane Bohnen (VP) | Bought (not open market) | — |
| May 5, 2026 | Kim Kelderman (CEO) | Bought (not open market) | — |
| May 5, 2026 | James Hippel (CFO) | Bought (not open market) | — |
| May 1, 2026 | Steven C. Crouse (President) | Sold (not open market) | $17.1K |
| May 1, 2026 | Steven C. Crouse (President) | Bought (not open market) | — |
| Apr 22, 2026 | James Hippel (CFO) | Sold (not open market) | $3.3M |
| Apr 22, 2026 | Kim Kelderman (CEO) | Sold (not open market) | $79.8K |
| Apr 22, 2026 | James Hippel (CFO) | Bought (not open market) | — |
| Apr 22, 2026 | Kim Kelderman (CEO) | Bought (not open market) | — |
| Apr 14, 2026 | Kim Kelderman (CEO) | Sold (not open market) | $1.9M |
| Apr 14, 2026 | Kim Kelderman (CEO) | Bought (not open market) | — |
| Apr 8, 2026 | April McClain Delaney (Congress) | Sold | $1K–$15K |
| Apr 3, 2026 | Shane Bohnen (VP) | Sold (not open market) | $39.3K |
| Apr 3, 2026 | Shane Bohnen (VP) | Bought (not open market) | — |
| Mar 26, 2026 | April McClain Delaney (Congress) | Sold | $1K–$15K |
| Mar 2, 2026 | Steven C. Crouse (President) | Bought (not open market) | — |
| Mar 2, 2026 | Steven C. Crouse (President) | Bought (not open market) | — |
| Mar 2, 2026 | Steven C. Crouse (President) | Bought (not open market) | — |
Who's trading TECH
- Steven C. Crouse, President: other filings, last Jun 2, 2026
- Amy E. Herr, Director: sold $437K (2 sales), last May 8, 2026
- James Hippel, CFO: other filings, last May 5, 2026
- Kim Kelderman, CEO: other filings, last May 5, 2026
- Shane Bohnen, VP: other filings, last May 5, 2026
- April McClain Delaney, Congress: bought $24K (3 buys), sold $32K (4 sales), last Apr 8, 2026
- Matthew McManus, President: other filings, last Feb 1, 2026
- William Geist, President: other filings, last Nov 3, 2025
- Rupert Vessey, Director: other filings, last Oct 30, 2025
- Robert V Baumgartner, Director: other filings, last Oct 30, 2025
- Julie L Bushman, Director: other filings, last Oct 30, 2025
- John L Higgins, Director: other filings, last Oct 30, 2025
- Joseph D Keegan, Director: other filings, last Oct 30, 2025
- Judith V. Klimovsky, Director: other filings, last Oct 30, 2025
- Alpna Seth, Director: other filings, last Oct 30, 2025
Get free alerts when an insider at BIO-TECHNE Corp files a new trade →